It is reported that atazanavir (HIV-1 protease inhibitor used in the treatment of HIV infection) inhibits UGT1A1 activity, while phenobarbital (a barbiturate antiepileptic agent) induces it [55]. This evidence concerns the gene UGT1A1 and HIV infectious disease.